Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ADT Inc (ADT) vs Centene Corp (CNC) Price & Performance

Centene CorpTrade

Price performance (Past 24H)

Key statistics

ADT Inc vs Centene Corp — how do they compare? ADT Inc trades at $7.39 (market cap $5.58B), while Centene Corp trades at $66.33 (market cap $32.89B). The key difference: Centene Corp is far larger — about 5.9× ADT Inc's market cap, and ADT Inc pays a 2.88% dividend while Centene Corp pays none. Which is the better fit depends on your goals.

ADTCNC
Market Cap
$5.58B$32.89B
Sector
IndustrialsHealth
52-Week High
$8.85$68.72
52-Week Low
$6.30$26.17
Enterprise Value
$13.27B$21.93B
Dividend Yield
2.88%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ADT Inc

ADT Inc is a provider of monitored security, interactive home and business automation, and related monitoring services in the United States and Canada. ADT offers residential, commercial, and multi-site customers a comprehensive set of burglary, video, access control, fire and smoke alarm, and medical alert solutions. It provides interactive home and business automation solutions designed to control access, react to movement, and sense carbon monoxide, flooding, changes in temperature or other environmental conditions, as well as address personal emergencies, such as injuries and medical emergencies. In addition, it offers professional monitoring of third-party devices through ADT Canopy platform. The product brands of the company are ADT and ADT Pulse, and Protection One brand.

Read more on ADT

About Centene Corp

Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.

Read more on CNC